|
Volumn 345, Issue 11, 2001, Pages 804-809
|
Cephalosporin allergy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
AMPICILLIN;
ANTIBIOTIC AGENT;
ANTIBODY;
AZTREONAM;
BETA LACTAM ANTIBIOTIC;
CEFACLOR;
CEFADROXIL;
CEFALEXIN;
CEFALORAM;
CEFALORIDINE;
CEFALOTIN;
CEFAMANDOLE;
CEFAPIRIN;
CEFAZOLIN;
CEFOPERAZONE;
CEFOTETAN;
CEFOTIAM;
CEFOXITIN;
CEFSULODIN;
CEFTAZIDIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
LORACARBEF;
MACROLIDE;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SULFONAMIDE;
UNINDEXED DRUG;
VANCOMYCIN;
ANAPHYLAXIS;
ANTIBIOTIC THERAPY;
CLINICAL PROTOCOL;
CROSS REACTION;
DESENSITIZATION;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
EOSINOPHILIA;
EXFOLIATIVE DERMATITIS;
FEVER;
HIGH RISK PATIENT;
HUMAN;
MAJOR CLINICAL STUDY;
PENICILLIN ALLERGY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SERUM SICKNESS;
SKIN TEST;
SKIN TOXICITY;
STEVENS JOHNSON SYNDROME;
CEPHALOSPORINS;
CROSS REACTIONS;
DRUG HYPERSENSITIVITY;
HUMANS;
PENICILLINS;
RISK FACTORS;
|
EID: 0035856014
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMra993637 Document Type: Review |
Times cited : (320)
|
References (50)
|